Anne Srikanth

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial

Vijay Patil, Vanita Noronha, Sachin Dhumal et al. · The Lancet Global Health · 2020 · 98 citations · Full text

Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial

Jyoti Bajpai, Venkatesh Kapu, Sushmita Rath et al. · The Lancet Oncology · 2024 · 37 citations

Oncology, Metronomic Therapy, Solid Tumours +6

The pattern of care in head-and-neck cancer: Comparison between before and during the COVID-19 pandemic

Kumar Prabhash, VijayM Patil, Anne Srikanth et al. · Cancer Research Statistics and Treatment · 2020 · 28 citations · Full text

Population Health Sciences, Cancer Registration, Covid-19 +25

Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer

Vanita Noronha, Vijay Patil, Pankaj Chaturvedi et al. · European Journal of Cancer · 2024 · 11 citations